Table 4 Distribution of HPV Positives among the Cervical Cancer types in the study population
Cancer Type | Total | |||
|---|---|---|---|---|
HPV Positive | SCC | Adenocarcinoma | p-value | |
HPV59 | 75 (40.1%) | 11 (42.3%) | 86 (40.4%) | 0.495 |
HPV35 | 59 (31.6%) | 8 (30.8%) | 67 (31.5%) | 0.566 |
HPV18 | 59 (31.6%) | 5 (19.2%) | 64 (30%) | 0.145 |
HPV16 | 29 (15.5%) | 3 (11.5%) | 32 (15%) | 0.426 |
HPV33 | 16 (8.6%) | 6 (23.1%) | 22 (10.3%) | 0.035 |
HPV45 | 17 (9.1%) | 5 (19.2%) | 22 (10.3%) | 0.110 |
HPV66 | 17 (9.1%) | 5 (19.2%) | 22 (10.3%) | 0.110 |
HPV68 | 15 (8%) | 5 (19.2%) | 20 (9.4%) | 0.078 |
HPV52 | 15 (8%) | 1 (3.8%) | 16 (7.5%) | 0.392 |
HPV58 | 9 (4.8%) | 0 (0%) | 9 (4.2%) | 0.302 |
HPV56 | 6 (3.2%) | 2 (7.7%) | 8 (3.8%) | 0.253 |
HPV31 | 6 (3.2%) | 1 (3.8%) | 7 (3.3%) | 0.604 |
HPV39 | 5 (2.7%) | 0 (0%) | 5 (2.3%) | 0.518 |
HPV51 | 4 (2.1%) | 0 (0%) | 4 (1.9%) | 0.592 |
HPV53 | 1 (0.5%) | 1 (3.8%) | 2 (0.9%) | 0.230 |
Total (Within HPV) | 187 (87.8%) | 26 (12.2%) | 213 (100.0%) | |